Dow Jones Industrial Average Rallies 396; S&P Out of Correction

S&P Rookies: Buy or Beware?

by Karee Venema

Published on Jan 29, 2016 at 4:25 PM

Stocks put a dent in their monthly deficit, though it was still the worst January since 2009. The Dow Jones Industrial Average (DJIA) enjoyed a triple-digit win, while the S&P 500 Index (SPX) managed to claw its way out of correction territory. An unexpected move by the Bank of Japan and well-received earnings for Microsoft Corporation (NASDAQ:MSFT) and Visa Inc (NYSE:V) helped divert traders' attention from a mixed batch of economic reports and disappointing tech earnings. Meanwhile, another day of upside for oil only stoked the bullish flames.


Continue reading for more on today's market, including
:

The Dow Jones Industrial Average (DJIA - 16,466.30) spent the whole day in the green, settling with a 396.7-point, or 2.5%, gain. All 30 of the Dow's components gained ground, led by V's 7% pop. For the week, the DJI added 2.3% -- a second straight weekly victory -- but slumped 5.5% on the month.

The S&P 500 Index (SPX - 1,940.24) jumped 46.9 points, or 2.5%, while the Nasdaq Composite (COMP - 4,613.95) underperformed its peers with a 107.3-point, or 2.4%, advance. Week-over-week, the SPX and COMP added 1.6% and 0.3%, respectively. On a monthly basis, the SPX fell 5.2%, while the COMP plunged 8%.

The CBOE Volatility Index (VIX - 20.20), meanwhile, shed 2.2 points, or 9.9%, to close at its lowest level since Jan. 5. The market's "fear gauge" surrendered 9.6% on the week, but gained 10.9% on the month.

160129Recap1

160129Recap2

5 Items on Our Radar Today:

  1. The advance reading on gross domestic product (GDP) showed the U.S. economy grew at a 0.7% rate in the fourth quarter, as the dollar strengthened and demand for exports slowed. This arrived in line with economists' estimate, but was far short of the 2% GDP growth in the third quarter. (CNBC)

  2. The Thomson Reuters/University of Michigan consumer sentiment index dropped to 92.0 from 92.6 in January. The index hit its highest post-recession peak of 98.1 one year ago. Meanwhile, the Chicago purchasing managers index (PMI) arrived at 55.6 this month -- its loftiest perch since last January -- signaling expansion in the region. (MarketWatch; CNBC)

  3. XRX not only announced plans to split into two, but said Carl Icahn will now hold three seats on the board. The activist investor disclosed a stake in XRX last November.

  4. While Merck & Co., Inc. (NYSE:MRK) was rising on news of a regulatory nod, this sector peer jumped on positive data for its diabetes drug.

  5. Schaeffer's contributor Adam Warner offers his two cents on the best way to sell premium.

160129Recap3

160129Recap4  
Data courtesy of Trade-Alert

Commodities:

Crude oil rose for a fourth straight day -- a feat not accomplished since April -- as the U.S. active rig count declined for a sixth consecutive week. By the close, crude for March delivery was up 40 cents, or 1.2%, at $33.62 per barrel. Crude advanced 4.4% for the week -- its second in a row -- but declined for a third straight month, down 9.2%.

A lackluster GDP reading helped send gold higher today, with the April-dated contract rising 30 cents to $1,116.40 per ounce. On the week, the malleable metal added 1.8%, while month-over-month, gold tacked on 5%. It was gold's best monthly showing since last January.


A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Wall Street Roars Higher Amid Civil Unrest
Investors weighed a mixed bag of jobs data
AstraZeneca Stock Flat Despite COVID-19 Vaccine News
AstraZeneca saw a rise in capacity for its COVID-19 vaccine candidate
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.